全球生命科学
概述
Featured News & Insights
0015
Contacts
Services
Advising on the full scope of regulatory, compliance and enforcement, litigation and transactional matters, we can offer you a holistic legal approach that will smooth your path as you navigate industry changes, technological advances, market demands and policy hurdles.
Regions
From high-profile transactions to regulatory issues and complex litigation, we collaborate across borders and disciplines to help our clients in more than 70 countries face challenges and embrace opportunities.

All Professionals
sort
Capabilities
Related Resources
Related Blogs
News & Insights
Sidley Healthcare Investment Conference 2026Tuesday, September 22, 2026Sidley Represents GSK in Connection With Its €3.5 Billion Issuance of NotesSeptember 17, 2026HHS Secretary Announces Intent to Extend HHS-OIG Exclusion Authority to CMS, Expanding the Administration’s Anti-Fraud CampaignSeptember 16, 2026FDA and SEC Announce Coordination on Scrutiny of Public DisclosuresSeptember 16, 2026
活动
公告
GoodLifeSci
Food, Drug and Medical Device Update
FDA and SEC Announce Coordination on Scrutiny of Public DisclosuresSeptember 16, 2026Illinois Expands Attorney General Review of Healthcare TransactionsAugust 13, 2026Shifting Expectations: FDA Takes a First Step Toward Making GRAS Notifications MandatoryAugust 12, 2026The Evolving Global Landscape for Orphan Drug ExclusivityJuly 28, 2026
Food, Drug and Medical Device Update
Healthcare Update
Food, Drug and Medical Device Update
Global Life Sciences Update
New York Ethics Opinion Warns Lawyers on Qui Tam DeceptionSeptember 2, 2026Recent ESG Developments in EuropeAugust 2026Through the Looking Glass: What WHA79 Reveals About the Future of Global Life SciencesAugust 2026Switzerland Expands Integrity Rules to Medical Devices: Key Compliance Implications for Medtech CompaniesAugust 2026
Law360
Sidley Life Sciences Briefing
Sidley Life Sciences Briefing
Sidley Life Sciences Briefing
Sidley Represents GSK in Connection With Its €3.5 Billion Issuance of NotesSeptember 17, 2026Sidley Represents American Healthcare REIT in US$819 Million Common Stock OfferingSeptember 14, 2026Sidley Represents Verily Health in Investment from NVIDIASeptember 11, 2026Sidley Represents Vegamour in Its Acquisition by Belle BrandsSeptember 9, 2026
公告
公告
公告
公告
Sidley Wins Seven Honors at the 2026 LMG Life Sciences Americas AwardsSeptember 11, 2026Managing IP Recognizes Sidley and 12 Lawyers in IP Stars 2026July 31, 2026Sidley Shortlisted in 16 Categories at the LMG Life Sciences Americas Awards 2026July 20, 2026Sidley Highly Ranked in Chambers USA 2026June 4, 2026
荣誉
荣誉
荣誉
荣誉
HHS Secretary Announces Intent to Extend HHS-OIG Exclusion Authority to CMS, Expanding the Administration’s Anti-Fraud CampaignSeptember 16, 2026When AI Changes The Deal: Seven AI-related Considerations for Life Sciences M&A DealmakersSeptember 8, 2026Is my product a medical device? EU Court judgment clarifies that the test includes objective function and intended purpose, and provides guidance relevant to software and AI-enabled toolsAugust 31, 2026UK Looks To Modernize Medicines And Medical Device Regulation In The Era Of AIAugust 26, 2026
GoodLifeSci
GoodLifeSci
GoodLifeSci
GoodLifeSci






































